Get the Stockscreener App
184.03
16.11%
25.53
Pre-market:
186.51
2.48
+1.35%
Twist Bioscience Corp stock is traded at $184.03, with a volume of 3.53M.
It is up +16.11% in the last 24 hours and up +30.70% over the past month.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
See More
Previous Close:
$158.50
Open:
$157.72
24h Volume:
3.53M
Relative Volume:
2.00
Market Cap:
$12.20B
Revenue:
$409.48M
Net Income/Loss:
$-81.28M
P/E Ratio:
-138.51
EPS:
-1.3286
Net Cash Flow:
$-95.14M
1W Performance:
+18.30%
1M Performance:
+30.70%
6M Performance:
+287.51%
1Y Performance:
+581.09%
1-Day Range:
$156.83
$185.22
1-Week Range:
$156.16
$185.22
52-Week Range:
$23.30
$185.22
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
184.03 | 12.20B | 409.48M | -81.28M | -95.14M | -1.3286 |
TMO
Thermo Fisher Scientific Inc
|
678.39 | 250.83B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
223.77 | 157.31B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
408.79 | 58.92B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
172.84 | 48.73B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
275.02 | 45.27B | 16.63B | 1.39B | 2.12B | 8.0674 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-25 | Initiated | Stephens | Overweight |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Biotech Stocks At 52-Week HighsCDNA +13%, GRAL +15%, TWST +16%, ADPT, RVTY - RTTNews
Twist Bioscience Stock Jumped 16% Thursday. Leerink Says Anthropic Made It Happen. - finance.yahoo.com
Form 144 Twist Bioscience Corp For: 24 September By Investing.com - Investing.com South Africa
A proposed share sale valued at $922,906 names Emily M. Leproust as the Twist Bioscience (TWST) account holder. - Stock Titan
Twist Bioscience Shares Hit New 52-Week High - AskTraders
U.S. Markets Finished Mixed Thursday As Twist Bioscience Led, Gen Digital Lagged - Barron's
Twist Bioscience TWST Surges On Lilly AI Deal, Target Hike - StocksToTrade
Twist Bioscience stock hits 52-week high at 170.69 USD - Investing.com
Twist Bioscience stock hits 52-week high at 170.69 USD By Investing.com - Investing.com Nigeria
Twist Bioscience Corp Stock (TWST) Moved Up by 11.04% on Sep 24: A Full Analysis - TradingKey
TWST Forecast — Price Target — Prediction for 2027 - TradingView
ETFs Investing in Twist Bioscience Corp. Stocks - TradingView
EBITDA of Twist Bioscience Corp. – BMV:TWST - TradingView
Twist Bioscience Corp. Revenue Breakdown – BMV:TWST - TradingView
At $165.4910 a share, Twist Bioscience (TWST) CEO Emily M. Leproust sold stock to cover taxes. - Stock Titan
A required tax-withholding sale: Twist Bioscience (TWST) HR executive Paula Green sells 294 shares. - Stock Titan
Twist Bioscience Corporation (TWST) Stock Price, News, Quote & History - Yahoo! Finance Canada
Twist Bioscience Corporation (TWST) stock price, news, quote and history - Yahoo Finance UK
Twist Bioscience Corporation (TWST) Latest Stock News & HeadlinesYahoo Finance - Yahoo! Finance Canada
Form 144 Twist Bioscience Corp For: 22 September By Investing.com - Investing.com Canada
Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership - finance.yahoo.com
Twist Bioscience CEO Emily Leproust sells $56.3m in company stock - Investing.com
After $56M sale, Twist Bioscience (NASDAQ: TWST) insider plans more - Stock Titan
Twist Bioscience (TWST) officer to sell shares to cover tax on equity award - Stock Titan
After $1.8M stock sale, Twist Bioscience (NASDAQ: TWST) insider files to sell more - Stock Titan
Twist Bioscience CEO Emily Leproust sells $56.3m in company stock By Investing.com - Investing.com South Africa
Twist Bioscience (TWST) CEO trades 356K shares at up to $163.60 - Stock Titan
Weekly Recap: FY2026 revenue guide raised and Anthropic model review - TradingView
Twist Bioscience CorporationCommon Stock (NQ: TWST - The Chronicle-Journal
Twist Bioscience Corp (0ME) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Twist Bioscience Corp (0ME) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Why Twist Bioscience Stock Skyrocketed This Week - finance.yahoo.com
TWST Jumps As Twist Bioscience Lands Eli Lilly AI Drug Discovery Deal - StocksToTrade
Twist Bioscience (NASDAQ: TWST) holder eyes $44.7M stock sale - Stock Titan
New multimillion-dollar stock sale planned at Twist Bioscience (NASDAQ: TWST) - Stock Titan
Twist Bioscience Stock Jumps 11% on Lilly TuneLab Deal, but the Revenue Terms Are Missing - TechStock²
TWST Stock Hits Multi-Year High, But ‘Pharma Bro’ Martin Shkreli Calls Twist A Short - Stocktwits
Twist Bioscience stock hits 52-week high at 155.51 USD By Investing.com - Investing.com Australia
TWST Maintained by Leerink Partners -- Price Target Raised to $1 - GuruFocus
Twist Bioscience stock hits 52-week high at 155.51 USD - Investing.com
TWST Looks 186.1% Overvalued on GF Value™ - GuruFocus
Twist Bioscience (TWST) Is Up 14.0% After Lilly AI Drug Discovery Tie-Up Is AnnouncedHas The Bull Case Changed? - finance.yahoo.com
Twist Bioscience Corp (0ME) Q3 2026 Earnings ReportResults, Call & Slides - TipRanks
Twist Bioscience stock rises on Eli Lilly partnership deal By Investing.com - Investing.com Canada
Why is Twist Bioscience stock rallying today? - Investing.com
Twist Bioscience stock rises on Eli Lilly partnership deal - Investing.com
Lilly TuneLab, Twist Bioscience Partner on Antibody Drug Discovery - contractpharma.com
Beyond Hype: Twist Bioscience Secures Data Pipeline Role In Eli Lilly TuneLab Ecosystem - Benzinga
AI and Next-Gen Sequencing Strengthens Twist Bioscience Corp. (TWST) - finance.yahoo.com
LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday - Benzinga
Twist joins Lilly's TuneLab as preferred antibody characterization data provider - allsci.com
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):